Analysts expect Viridian Therapeutics, Inc.\DE to report revenue of 28,433.04 for Q2 26, against a range of 26,109.01 to 30,757.07. The most recent reported quarter, Q1 26, came in at 141,000.00, a 267.6% beat against the 38,355.93 consensus.
| Metric | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 72,000.00 | 86,000.00 | 72,000.00 | 72,000.00 | 75,000.00 | 70.57 M | 132,000.00 | 141,000.00 | - | - | - | - | - | - | - | - | |||||||||||
| High Estimate | 80,774.00 | 90,540.05 | 45,069.09 | 54,347.02 | 53,861.79 | 34,213.90 | 18.20 M | 40,724.22 | 30,757.07 | 4.14 M | 18.52 M | 43.33 M | 12.36 M | 29.52 M | 68.33 M | 162.33 M | |||||||||||
| Low Estimate | 67,128.78 | 75,763.03 | 40,972.47 | 50,524.76 | 44,579.29 | 31,824.12 | 16.83 M | 35,987.64 | 26,109.01 | 3.68 M | 15.82 M | 40.66 M | 10.83 M | 26.10 M | 62.57 M | 143.91 M | |||||||||||
| Consensus Estimate | 73,951.39 | 83,151.54 | 43,020.78 | 52,435.89 | 49,220.54 | 33,019.01 | 17.52 M | 38,355.93 | 28,433.04 | 3.91 M | 17.17 M | 42.00 M | 11.60 M | 27.81 M | 65.45 M | 153.12 M |
Analysts expect Viridian Therapeutics, Inc.\DE to report earnings per share of -0.98 for Q2 26, against a range of -1.04 to -0.92. The most recent reported quarter, Q1 26, came in at -0.90, a 10.9% beat against the -1.01 consensus.
| Metric | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.02 | -1.15 | -0.81 | -0.87 | -1.00 | -0.34 | -1.08 | -0.90 | - | - | - | - | - | - | - | - | |||||||||||
| High Estimate | -0.87 | -1.07 | -1.04 | -0.97 | -1.01 | -1.02 | -0.99 | -0.95 | -0.92 | -0.82 | -0.80 | -0.73 | -0.76 | -0.61 | -0.76 | -0.10 | |||||||||||
| Low Estimate | -0.93 | -1.17 | -1.16 | -1.05 | -1.11 | -1.14 | -1.07 | -1.07 | -1.04 | -0.98 | -0.96 | -0.77 | -0.88 | -0.67 | -0.84 | -0.12 | |||||||||||
| Consensus Estimate | -0.90 | -1.12 | -1.10 | -1.01 | -1.06 | -1.08 | -1.03 | -1.01 | -0.98 | -0.90 | -0.88 | -0.75 | -0.82 | -0.64 | -0.80 | -0.11 |